NCT00978757View on ClinicalTrials.gov

The Effect of Ketamine on Interleukin-6 Synthesis in Hepatic Resections Requiring Temporary Porto-arterial Occlusion

PHASE4CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

June 30, 2001

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Hepatectomy
Interventions
DRUG

Ketamine

Ketamine: 0.25 mg/kg, intravenously, one dose.

OTHER

Placebo

saline solution

Trial Locations (1)

1181

Hospital Italiano de Buenos Aires, Buenos Aires

All Listed Sponsors
lead

Hospital Italiano de Buenos Aires

OTHER

NCT00978757 - The Effect of Ketamine on Interleukin-6 Synthesis in Hepatic Resections Requiring Temporary Porto-arterial Occlusion | Biotech Hunter | Biotech Hunter